Manylion am y math o ddogfen lywodraethu sydd gan yr elusen a phan y'i sefydlwyd. Nid dyma destun llawn dogfen lywodraethu'r elusen.
MEMORANDUM AND ARTICLES INCORPORATED 03 MAY 1989
AS AMENDED BY SPECIAL RESOLUTION(S) DATED 19 FEB 1990
AS AMENDED BY SPECIAL RESOLUTION(S) DATED 25 MAY 1990
AS AMENDED BY SPECIAL RESOLUTION(S) DATED 06 APR 2004
AS AMENDED BY SPECIAL RESOLUTION(S) DATED 21 JUN 2007
AS AMENDED BY CERTIFICATE OF INCORPORATION ON CHANGE OF NAME DATED 18 FEB 2013
AS AMENDED BY SPECIAL RESOLUTION(S) DATED 06 APR 2017
AS AMENDED BY SPECIAL RESOLUTION REGISTERED AT COMPANIES HOUSE ON 24 APR 2017 as amended on 24 Jan 2022
Gwrthrychau elusennol
THE OBJECTS FOR WHICH THE COMPANY IS
ESTABLISHED ARE:
2.1 THE RELIEF, TREATMENT, CURE OR SUPPORT OF THOSE WITH BLOOD CANCERS OR OTHER BLOOD DISORDERS OR AFFECTED BY AN IMMUNOLOGICAL DEFICIENCY AND ANY SIMILAR OR RELATED DISEASES OR CONDITIONS (INCLUDING THE PROVISION OF SUPPORT TO THEIR FAMILY MEMBERS OR CARERS);
2.2 THE RELIEF, TREATMENT, CURE OR SUPPORT OF THOSE WHO REQUIRE A STEM CELL TRANSPLANT OR WHO ARE AFFECTED BY ANY DISEASE OR CONDITION THAT MAY BE RELIEVED, TREATED OR CURED BY ANY ORGAN OR STEM CELL TRANSPLANT (INCLUDING THE PROVISION OF SUPPORT TO THEIR FAMILY MEMBERS OR CARERS);
2.3 THE ADVANCEMENT OF RESEARCH INTO THE CAUSES OF AND THE DIAGNOSIS, RELIEF, TREATMENT OR CURE OF THOSE REQUIRING A STEM CELL TRANSPLANT OR WHO ARE AFFECTED BY AN IMMUNOLOGICAL DEFICIENCY OR ANY SIMILAR OR RELATED
DISEASES OR CONDITIONS AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH; AND
2.4 THE ADVANCEMENT OF RESEARCH INTO IMPROVING ORGAN OR STEM CELL CURRENT NEW
TRANSPLANTATION OR ANY RELATED TECHNIQUE OR TECHNOLOGY AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH.
Maes buddion
Y maes y gall yr elusen weithredu ynddo, fel y nodir yn ei dogfen lywodraethu.
